Literature DB >> 11923639

Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization.

Susanne Wagner1, Jorg Schnorr, Herbert Pilgrimm, Bernd Hamm, Matthias Taupitz.   

Abstract

RATIONALE AND
OBJECTIVES: Preclinical in-vivo characterization of a newly developed MR contrast medium consisting of very small superparamagnetic iron oxide particles (VSOP) coated with citrate (VSOP-C184).
METHODS: VSOP-C184 (core diameter: 4 nm; total diameter: 8.6 nm; relaxivities in water at 0.94 T (T1) 20.1 and (T2) 37.1 l/[mmol*sec]) was investigated to determine its pharmacokinetics, efficacy, acute single dose toxicity, repeated dose toxicity, and genotoxicity.
RESULTS: The plasma elimination half-life at 0.045 mmol Fe/kg was 21.3 +/- 5.5 minutes in rats and 36.1 +/- 4.2 minutes in pigs, resulting in a T1-relaxation time of plasma of < 100 milliseconds for 30 minutes in pigs. The particles are mainly cleared via the phagocytosing system of the liver. MR angiography at a dose of 0.045 mmol Fe/kg shows an excellent depiction of the thoracic and abdominal vasculature in rats and of the coronary arteries in pigs. The LD50 in mice is > 17.9 mmol Fe/kg. A good tolerance and safety profile was found.
CONCLUSIONS: The experiments indicate, that VSOP-C184 may be a well tolerated and safe contrast medium for MR imaging that can be effectively used for MR angiography including visualization of the coronary arteries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923639     DOI: 10.1097/00004424-200204000-00002

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  31 in total

Review 1.  [Cell tracking. Principles and applications].

Authors:  J Grimm; M F Kircher; R Weissleder
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

2.  Preparation and acute toxicology of nano-magnetic ferrofluid.

Authors:  Zefeng Xia; Guobin Wang; Kaixiong Tao; Jianxing Li; Yuan Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 3.  [Molecular and parametric imaging with iron oxides].

Authors:  L Matuszewski; B Tombach; W Heindel; C Bremer
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

4.  Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Authors:  Stephan Metz; Ambros J Beer; Marcus Settles; Jaroslav Pelisek; René M Botnar; Ernst J Rummeny; Peter Heider
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

Review 5.  Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications.

Authors:  David E Sosnovik; Matthias Nahrendorf; Ralph Weissleder
Journal:  Basic Res Cardiol       Date:  2008-03       Impact factor: 17.165

6.  Migration of monocytes after intracerebral injection.

Authors:  Miriam Kaminski; Ingo Bechmann; Jürgen Kiwit; Jana Glumm
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

Review 7.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

Review 8.  MRI as a tool to monitor islet transplantation.

Authors:  Zdravka Medarova; Anna Moore
Journal:  Nat Rev Endocrinol       Date:  2009-06-23       Impact factor: 43.330

Review 9.  Bioresponsive nanosensors in medical imaging.

Authors:  Eyk Schellenberger
Journal:  J R Soc Interface       Date:  2009-10-21       Impact factor: 4.118

Review 10.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.